
“After progress in a second round of tests using stem cells to regrow nerve fibres, the China Spinal Cord Injury Network (ChinaSCINet) has applied for regulatory approval in China for a third and final phase, which it hopes to start in the autumn. 15 out of 20 patients in the Chinese city of Kunming, who received umbilical cord blood cell transplants and intensive walking therapy, were on average able to walk with minimal assistance seven years after complete spinal cord injury. The treatment involves injecting umbilical cord blood mononuclear cells into patients’ damaged spines to help regenerate nerves, while lithium is used to promote the growth of the nerve fibres.”
Related posts:
FHA exhausts reserves, may need bailout
Amid the Greek Crisis, Bitcoin Reminds Everyone It’s Not Perfect
Out of the 'Shadows': Pot Sellers Can Now Do Business With Banks
Taxpatriate? Tax dodgers welcome to leave, not welcome to return
Swiss Space Systems aims for low-cost satellite service
Credit agencies dropping claims that they are 'independent'
US Bid to Contain Russia and Latin America Speeds New Alliances
Trial set for Tulsa police officer accused of robbing Hispanic drivers
Snapchat market value hits $800 million
Colonial flags fly in Hong Kong as anger grows over Chinese rule
Saudi allies Bahrain, Sudan and UAE join action against Iran
Taxes on 8,000 French households were greater than 100% of income last year
Michael Scheuer: The Idea That They're Attacking Us Because Of Our Freedom Is Insane
U.S. military prepares new aggressive rules to fight cyber war
Bank of China New York opens Queens branch